Phase 3 Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who report that their memory and thinking are not impaired.
- People who have sufficient reading ability, vision, and hearing to complete memory and thinking tests at the time of screening.
Who may not be able to join:
- People who have seen a doctor about concerns with their memory.
- People who have a history of, or have been diagnosed with, impaired memory or thinking, or a significant brain or nervous system condition that can affect cognition.
- People who are currently enrolled in, or have previously taken part in, any Alzheimer's Disease study that involved an investigational (not yet fully approved) drug.
- People who are currently using or have previously used prescription medications for mild cognitive impairment or dementia — this includes amyloid-targeting therapies (such as lecanemab, donanemab, or aducanumab), cholinesterase inhibitors (such as benzgalantamine, donepezil, galantamine, or rivastigmine), or memantine.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Phone: 1-317-615-4559
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to Cognitive Worsening Within Cohorts as Measured by Cognitive Composite or Any of the Individual Composite Components
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.